Summary Background The quantification of the burden of disease attributable to hepatitis B virus (HBV) infection and the adaptation of prevention and control measures requires knowledge on its ...prevalence in the general population. For most countries such data are not routinely available. We estimated the national, regional, and global prevalence of chronic HBV infection. Methods For this systematic review and pooled analysis, we searched for data on prevalence of chronic HBV infection published between Jan 1, 1965, and Oct 23, 2013, in the databases Medline, Embase, CAB Abstracts (Global health), Popline, and Web of Science. We included studies reporting the hepatitis B surface antigen (HBsAg) serological marker of chronic HBV infection in non-high-risk groups and extracted data into a customised database. For each country, we calculated HBsAg prevalence estimates and 95% CIs weighted by study size. We extrapolated prevalence estimates to population sizes in 2010 to obtain the number of individuals with chronic HBV infection. Findings Of the 17 029 records screened, 1800 report on the prevalence of HBsAg covering 161 countries were included. HBsAg seroprevalence was 3·61% (95% CI 3·61–3·61) worldwide with highest endemicity in countries of the African region (total 8·83%, 8·82–8·83) and Western Pacific region (total 5·26%, 5·26–5·26). Within WHO regions, prevalence ranged from 0·20% (0·19–0·21; Mexico) to 13·55% (9·00–19·89; Haiti) in the Americas, to 0·48% (0·12–1·90; the Seychelles) to 22·38% (20·10–24·83; South Sudan) in the African region. We estimated that in 2010, globally, about 248 million individuals were HBsAg positive. Interpretation This first global assessment of country-level population prevalence of chronic HBV infection found a wide variation between countries and highlights the need for continued prevention and control strategies and the collection of reliable epidemiologic data using standardised methodology. Funding World Health Organization.
Highlights ► Systematic review of global hepatitis B prevalence and modeling of data. ► HBsAg-positive persons increased from 223 million in 1990 to 240 million in 2005. ► HBsAg prevalence varied ...geographically with highest endemicity in sub-Saharan Africa. ► HBsAg prevalence decreased overall but global differences exist. ► Demographic changes call for targeted hepatitis B prevention.
Although epidemic jaundice was well known to physicians of antiquity, it is only in recent years that medical science has begun to unravel the origins of hepatitis A virus (HAV) and the unique ...pathobiology underlying acute hepatitis A in humans. Improvements in sanitation and the successful development of highly efficacious vaccines have markedly reduced the worldwide occurence of this enterically-transmitted infection over the past quarter century, yet the virus persists in vulnerable populations and those without HAV immunity and remains a common cause of food-borne disease outbreaks in economically-advantaged societies. Reductions in HAV incidence have led to increases in the median age at which infection occurs, often resulting in more severe disease in affected persons and paradoxical increases in disease burden in some developing nations. Here, we summarize recent advances in the molecular virology and epidemiology of HAV, an atypical member of the Picornaviridae family, survey what is known of the pathogenesis of hepatitis A in humans and the host-pathogen interactions that typify the infection. The article also reviews medical and public health aspects of HAV vaccination and disease prevention.
The human intestinal microbiota is a crucial factor in the pathogenesis of various diseases, such as metabolic syndrome or inflammatory bowel disease (IBD). Yet, knowledge about the role of ...environmental factors such as smoking (which is known to influence theses aforementioned disease states) on the complex microbial composition is sparse. We aimed to investigate the role of smoking cessation on intestinal microbial composition in 10 healthy smoking subjects undergoing controlled smoking cessation.
During the observational period of 9 weeks repetitive stool samples were collected. Based on abundance of 16S rRNA genes bacterial composition was analysed and compared to 10 control subjects (5 continuing smokers and 5 non-smokers) by means of Terminal Restriction Fragment Length Polymorphism analysis and high-throughput sequencing.
Profound shifts in the microbial composition after smoking cessation were observed with an increase of Firmicutes and Actinobacteria and a lower proportion of Bacteroidetes and Proteobacteria on the phylum level. In addition, after smoking cessation there was an increase in microbial diversity.
These results indicate that smoking is an environmental factor modulating the composition of human gut microbiota. The observed changes after smoking cessation revealed to be similar to the previously reported differences in obese compared to lean humans and mice respectively, suggesting a potential pathogenetic link between weight gain and smoking cessation. In addition they give rise to a potential association of smoking status and the course of IBD.
Hepatitis B virus (HBV) is divided into nine genotypes, A to I. Currently, it remains unclear how the individual genotypes contribute to the estimated 250 million chronic HBV infections. We performed ...a literature search on HBV genotyping data throughout the world. Over 900 publications were assessed and data were extracted from 213 records covering 125 countries. Using previously published HBV prevalence, and population data, we approximated the number of infections with each HBV genotype per country and the genotype distribution among global chronic HBV infections. We estimated that 96% of chronic HBV infections worldwide are caused by five of the nine genotypes: genotype C is most common (26%), followed by genotype D (22%), E (18%), A (17%) and B (14%). Genotypes F to I together cause less than 2% of global chronic HBV infections. Our work provides an up-to-date analysis of global HBV genotyping data and an initial approach to estimate how genotypes contribute to the global burden of chronic HBV infection. Results highlight the need to provide HBV cell culture and animal models that cover at least genotypes A to E and represent the vast majority of global HBV infections to test novel treatment strategies.
The motivation for exploring the potential development of accident tolerant fuels in light water reactors to replace existing Zr alloy clad monolithic (U, Pu) oxide fuel is outlined. The evaluation ...includes a brief review of core degradation processes under design-basis and beyond-design-basis transient conditions. Three general strategies for accident tolerant fuels are being explored: modification of current state-of-the-art zirconium alloy cladding to further improve oxidation resistance (including use of coatings), replacement of Zr alloy cladding with an alternative oxidation-resistant high-performance cladding, and replacement of the monolithic ceramic oxide fuel with alternative fuel forms.
Severity and incidence of vaccine-preventable infections with influenza viruses, s. pneumoniae and c. tetani increase with age. Furthermore, vaccine coverage in the elderly is often insufficient. The ...aim of this study is to identify socio-economic and knowledge-, attitude- and practice- (KAP)-related determinants of vaccination against influenza, pneumococcal disease and tetanus in the older German population.
We analysed data from a German nationally representative questionnaire-based KAP-survey on infection prevention and hygiene behavior in the elderly (n = 1223). We used logistic regressions to assess impacts of socio-demographic- and KAP-related variables on vaccine uptake in general and on tetanus-, influenza- and pneumococcal vaccination. To generate KAP-scores, we applied factor analyses and analysed scores as predictors of specific vaccinations.
A low rated personal health status was associated with a higher uptake of influenza vaccine whereas place of residence within Germany strongly impacted on pneumococcal vaccination. For tetanus and influenza vaccination, the strongest single vaccination predictor was attitude-related, i.e., the perceived importance of the vaccine (OR = 18.1, 95 % CI = 4.5-71.8; OR = 23.0, 95 % CI = 14.9-35.3, respectively). Pneumococcal vaccination was mostly knowledge-associated, i.e., knowing the recommendation predicted uptake (OR = 17.1, 95 % CI = 9.5-30.7). Regarding the generated KAP-scores, the practice-score reflecting vaccine related behavior such as having a vaccination record, was predictive for all vaccines considered. The knowledge-score was associated with influenza (OR = 1.3, 95 % CI = 1.0-1.6) and pneumococcal vaccination (OR = 1.2, 95 % CI = 1.0-1.5). Uniquely for influenza vaccination, the attitude-score was linked to vaccine uptake (OR = 1.1, 95 % CI = 1.0-1.1).
Our results indicate that predictors of vaccination uptake in the elderly strongly depend on vaccine type and that scores of KAP are useful and valid to condense information from numerous individual KAP-variables. While awareness for vaccinations against influenza and tetanus is fairly high already it might have to be increased for vaccinations against pneumocoocal infections.
Context.
The Galactic plane has been observed extensively by a large number of Galactic plane surveys from infrared to radio wavelengths at an angular resolution below 40′′. However, a 21 cm line and ...continuum survey with comparable spatial resolution is lacking.
Aims.
The first half of THOR data (
l
= 14.0°−37.9°, and
l
= 47.1°−51.2°, |
b
|≤ 1.25°) has been published in our data release 1 paper. With this data release 2 paper, we publish all the remaining spectral line data and Stokes I continuum data with high angular resolution (10′′–40′′), including a new H
I
dataset for the whole THOR survey region (
l
= 14.0−67.4° and |
b
|≤ 1.25°). As we published the results of OH lines and continuum emission elsewhere, we concentrate on the H
I
analysis in this paper.
Methods.
With the
Karl G. Jansky
Very Large Array (VLA) in C-configuration, we observed a large portion of the first Galactic quadrant, achieving an angular resolution of ≤40′′. At
L
Band, the WIDAR correlator at the VLA was set to cover the 21 cm H
I
line, four OH transitions, a series of H
nα
radio recombination lines (RRLs;
n
= 151 to 186), and eight 128 MHz-wide continuum spectral windows, simultaneously.
Results.
We publish all OH and RRL data from the C-configuration observations, and a new H
I
dataset combining VLA C+D+GBT (VLA D-configuration and GBT data are from the VLA Galactic Plane Survey) for the whole survey. The H
I
emission shows clear filamentary substructures at negative velocities with low velocity crowding. The emission at positive velocities is more smeared-out, likely due to higher spatial and velocity crowding of structures at the positive velocities. Compared to the spiral arm model of the Milky Way, the atomic gas follows the Sagittarius and Perseus Arm well, but with significant material in the inter-arm regions. With the C-configuration-only H
I
+continuum data, we produce an H
I
optical depth map of the THOR areal coverage from 228 absorption spectra with the nearest-neighbor method. With this
τ
map, we corrected the H
I
emission for optical depth, and the derived column density is 38% higher than the column density with optically thin assumption. The total H
I
mass with optical depth correction in the survey region is 4.7 × 10
8
M
⊙
, 31% more than the mass derived assuming the emission is optically thin. If we applied this 31% correction to the whole Milky Way, the total atomic gas mass would be 9.4–10.5 × 10
9
M
⊙
. Comparing the H
I
with existing CO data, we find a significant increase in the atomic-to-molecular gas ratio from the spiral arms to the inter-arm regions.
Conclusions.
The high-sensitivity and resolution THOR H
I
dataset provides an important new window on the physical and kinematic properties of gas in the inner Galaxy. Although the optical depth we derive is a lower limit, our study shows that the optical depth correction issignificant for H
I
column density and mass estimation. Together with the OH, RRL and continuum emission from the THOR survey, these new H
I
data provide the basis for high-angular-resolution studies of the interstellar medium in different phases.